MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, LENZ made $1.901M in revenue. -$42.18M in net income. Net profit margin of -2218.83%.

Income Overview

Revenue
$1.901M
Net Income
-$42.18M
Net Profit Margin
-2218.83%
EPS
-$1.32
Unit: Million (M) dollars
Revenue Breakdown
    • Product
    • License

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenue
1.901 -7* 12.5 5
Cost of sales
1.076 0* --
Selling, general and administrative
44.96 32* 27.596 12.796
Research and development
0 -1* 3.791 9.061
Total operating expenses
46.036 31* 31.387 21.857
Loss from operations
-44.135 -38* -18.887 -16.857
Other income (expense)
0.003 -1* -0.014 0.199
Interest income
2.644 4* 2.201 2.246
Total other income, net
2.647 3* 2.187 2.445
Net loss before income taxes
--35* -16.7 -14.412
Income tax expense
-0* 0 0.5
Net loss
-41.488 -35* -16.7 -14.912
Unrealized gain on marketable securities
-0.692 0* 0.189 -0.085
Comprehensive loss
-42.18 -35 -16.511 -14.997
Basic EPS
-1.32 -1.168 -0.59 -0.53
Diluted EPS
-1.32 -1.168 -0.59 -0.53
Basic Average Shares
31,352,702 29,819,902 28,540,519 28,079,071
Diluted Average Shares
31,352,702 29,819,902 28,540,519 28,079,071
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$42.18M Interest income$2.644M Other income(expense)$0.003M Net loss-$41.488M Unrealized gain onmarketable securities-$0.692M Total other income,net$2.647M Product$1.651M License$0.25M Loss from operations-$44.135M Total revenue$1.901M Total operatingexpenses$46.036M Selling, general andadministrative$44.96M Cost of sales$1.076M

LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics, Inc. (LENZ)